IL235317A0 - A compound for the treatment of metabolic disorders - Google Patents

A compound for the treatment of metabolic disorders

Info

Publication number
IL235317A0
IL235317A0 IL235317A IL23531714A IL235317A0 IL 235317 A0 IL235317 A0 IL 235317A0 IL 235317 A IL235317 A IL 235317A IL 23531714 A IL23531714 A IL 23531714A IL 235317 A0 IL235317 A0 IL 235317A0
Authority
IL
Israel
Prior art keywords
composition
metabolic disorders
treating metabolic
treating
disorders
Prior art date
Application number
IL235317A
Other languages
English (en)
Hebrew (he)
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of IL235317A0 publication Critical patent/IL235317A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL235317A 2012-04-23 2014-10-23 A compound for the treatment of metabolic disorders IL235317A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23
PCT/IB2013/053155 WO2013160811A1 (en) 2012-04-23 2013-04-22 Composition for treating metabolic disorders

Publications (1)

Publication Number Publication Date
IL235317A0 true IL235317A0 (en) 2014-12-31

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL235317A IL235317A0 (en) 2012-04-23 2014-10-23 A compound for the treatment of metabolic disorders

Country Status (16)

Country Link
US (1) US20150290265A1 (enEXAMPLES)
EP (1) EP2841080A4 (enEXAMPLES)
JP (1) JP2015514797A (enEXAMPLES)
KR (1) KR20150003862A (enEXAMPLES)
CN (1) CN104244962A (enEXAMPLES)
AU (1) AU2013254329A1 (enEXAMPLES)
BR (1) BR112014026326A2 (enEXAMPLES)
CA (1) CA2870907A1 (enEXAMPLES)
IL (1) IL235317A0 (enEXAMPLES)
IN (1) IN2014MN02269A (enEXAMPLES)
MX (1) MX2014012742A (enEXAMPLES)
NZ (1) NZ701133A (enEXAMPLES)
RU (1) RU2014145931A (enEXAMPLES)
SA (1) SA113340494B1 (enEXAMPLES)
TW (1) TW201343174A (enEXAMPLES)
WO (1) WO2013160811A1 (enEXAMPLES)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016099944A1 (en) * 2014-12-19 2016-06-23 Halo Life Science, Llc Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
EP3529245A4 (en) 2016-10-24 2020-12-23 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THE LATEST
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
AU2019207737B2 (en) 2018-01-10 2023-07-13 Brightseed, Inc. Method for modulating metabolism
WO2019183587A1 (en) 2018-03-23 2019-09-26 Yumanity Therapeutics, Inc. Compounds and uses thereof
KR20220007845A (ko) 2019-01-24 2022-01-19 유마니티 테라퓨틱스, 인크. 화합물 및 이의 용도
AU2020383340A1 (en) 2019-11-11 2022-06-09 Brightseed, Inc Extract, consumable product and method for enriching bioactive metabolite in an extract
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
KR102408566B1 (ko) * 2020-04-09 2022-06-16 대한민국 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (ja) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk 糖尿病疾患予防・治療剤
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤
JP2008537539A (ja) * 2005-02-23 2008-09-18 アヴェスタジェン リミテッド 植物抽出物およびそのための方法と使用

Also Published As

Publication number Publication date
NZ701133A (en) 2016-08-26
EP2841080A4 (en) 2015-11-25
TW201343174A (zh) 2013-11-01
CA2870907A1 (en) 2013-10-31
EP2841080A1 (en) 2015-03-04
US20150290265A1 (en) 2015-10-15
MX2014012742A (es) 2015-04-08
BR112014026326A2 (pt) 2017-06-27
JP2015514797A (ja) 2015-05-21
CN104244962A (zh) 2014-12-24
IN2014MN02269A (enEXAMPLES) 2015-07-24
WO2013160811A1 (en) 2013-10-31
RU2014145931A (ru) 2016-06-20
SA113340494B1 (ar) 2015-12-24
KR20150003862A (ko) 2015-01-09
AU2013254329A1 (en) 2014-11-13

Similar Documents

Publication Publication Date Title
ZA201404676B (en) Compositions and methods for treating metabolic disorders
KR102297388B9 (ko) 대사장애를 치료하기 위한 아커만시아의 용도
IL233506B (en) Biguind preparations for the treatment of metabolic disorders
PT2726099T (pt) Método para o tratamento de distúrbios metabólicos
IL235317A0 (en) A compound for the treatment of metabolic disorders
GB201217441D0 (en) Composition
GB201200707D0 (en) Composition
IL239395A0 (en) Diclofenac preparation
EP2878295A4 (en) COMPOSITION
IL237483A0 (en) Preparations for the treatment of psoriasis
GB201420971D0 (en) Therapeutic composition
GB201206035D0 (en) Composition
EP2812190A4 (en) SURFACE TREATMENT COMPOSITION
IL234616A0 (en) A herbal preparation for the treatment of metabolic diseases
SI2617412T1 (sl) Sestavek za topično zdravljenje
EP2910537A4 (en) AGENT COMPOSITION GENERATING GAS
GB201209597D0 (en) Composition
GB201208133D0 (en) Composition
HK40121312A (en) Use of akkermansia for treating metabolic disorders
GB201207363D0 (en) Compounds for the treatment of metabolic disorders
GB201207359D0 (en) Compounds for the treatment of metabolic disorders
IL213610A0 (en) Composition for treating dermatological conditions
GB201214237D0 (en) Novel therapeutic composition
GB201106154D0 (en) Compounds for the treatment of metabolic disorders
GB201106142D0 (en) Compounds for the treatment of metabolic disorders